[Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005424:Flecainide / Q000009:adverse effects; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000009:adverse effects; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011405:Propafenone / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D011405:Propafenone; D005424:Flecainide; D000638:Amiodarone
Aggravamento di aritmie ventricolari all'ECG dinamico in pazienti trattati con farmaci antiaritmici.